Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 60
Healthy Volunteers: f
View:

• Patients with acute burn admitted to burn ICU within 24 hours from the burn incidence.

• patients with burn percentage of 25% to 50% of total body surface area

• patients with second to third degree burns

• ASA 1 and ASA 2 patients

Locations
Other Locations
Egypt
Ain Shams University
RECRUITING
Cairo
Contact Information
Primary
Ahmed H Elsayed, M.B.B.CH
AhmedHanyAbdelfatah@med.asu.edu.eg
+201016305451
Time Frame
Start Date: 2025-01-10
Estimated Completion Date: 2025-07-10
Participants
Target number of participants: 70
Treatments
Experimental: Burn ICU patients
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10. Treatment plan will be initiated to all patients according to the burn ICU protocol.
Related Therapeutic Areas
Sponsors
Leads: Ain Shams University

This content was sourced from clinicaltrials.gov